Compare EDSA & SONM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EDSA | SONM |
|---|---|---|
| Founded | 2015 | 1999 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.5M | 6.2M |
| IPO Year | 2018 | 2019 |
| Metric | EDSA | SONM |
|---|---|---|
| Price | $15.33 | $5.17 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $5.00 | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 19.4K |
| Earning Date | 05-08-2026 | 04-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $58,298,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.72 | $0.52 |
| 52 Week High | $20.32 | $12.30 |
| Indicator | EDSA | SONM |
|---|---|---|
| Relative Strength Index (RSI) | 63.62 | 63.81 |
| Support Level | $1.65 | $4.75 |
| Resistance Level | $20.32 | $5.45 |
| Average True Range (ATR) | 2.60 | 0.51 |
| MACD | 0.30 | 0.10 |
| Stochastic Oscillator | 63.55 | 83.24 |
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
DNA X Inc is engaged in providing crypto trading services through its online platform, enabling users to buy, sell, and exchange cryptocurrencies, as well as execute automated trading strategies between currency pairs. The company generates revenue from commissions and fees on trading activity.